Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Y Yu

Showing results (21-30 of 234) with videos related to

Pageof 24
Sort By:
Journal of Hematology & Oncology|November 15, 2015
Persistent androgen receptor addiction in castration-resistant prostate cancerMichael T Schweizer, Evan Y Yu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Cardiovascular Mortality in Testicular Nonseminomatous Germ Cell Tumors: Does Statistical Significance Imply Clinical Significance?Jorge D Ramos, Evan Y Yu
Current Treatment Options in Oncology|January 12, 2021
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current LimitationsRisa L Wong, Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2025
Early and Precise: Treating HRR Alterations in Hormone-Sensitive Prostate CancerLaura S Graham, Evan Y Yu
European Urology Focus|October 6, 2018
What Do the Guidelines Say for Metastatic Prostate Cancer Starting Androgen Deprivation Therapy? National Comprehensive Cancer Network, European Society for Medical Oncology, and European Association of Urology recommendationsEvan Y Yu, Silke Gillessen, Nicolas Mottet
Journal of Hematology & Oncology|May 14, 2015
Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapyHeather H Cheng, Colleen Soleau, Evan Y Yu
Clinical Genitourinary Cancer|December 3, 2014
Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamideAndrew J Cowan, Yoshio Inoue, Evan Y Yu
Clinical Genitourinary Cancer|August 28, 2014
Long-term survival in bone-predominant metastatic urothelial carcinomaJorge D Ramos, Heather H Cheng, Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Honing in on PARPi Response in Prostate Cancer: from HR Pathway to Gene-by-Gene GranularityAlexandra O Sokolova, Evan Y Yu, Heather H Cheng
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2021
BiTE-ing into Prostate Cancer with Bispecific T-cell EngagersNikhil V Kamat, Evan Y Yu, John K Lee
Pageof 24

Showing results (21-30 of 234) with videos related to

Sort By:
Pageof 24
Journal of Hematology & Oncology|November 15, 2015
Persistent androgen receptor addiction in castration-resistant prostate cancerMichael T Schweizer, Evan Y Yu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Cardiovascular Mortality in Testicular Nonseminomatous Germ Cell Tumors: Does Statistical Significance Imply Clinical Significance?Jorge D Ramos, Evan Y Yu
Current Treatment Options in Oncology|January 12, 2021
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current LimitationsRisa L Wong, Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2025
Early and Precise: Treating HRR Alterations in Hormone-Sensitive Prostate CancerLaura S Graham, Evan Y Yu
European Urology Focus|October 6, 2018
What Do the Guidelines Say for Metastatic Prostate Cancer Starting Androgen Deprivation Therapy? National Comprehensive Cancer Network, European Society for Medical Oncology, and European Association of Urology recommendationsEvan Y Yu, Silke Gillessen, Nicolas Mottet
Journal of Hematology & Oncology|May 14, 2015
Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapyHeather H Cheng, Colleen Soleau, Evan Y Yu
Clinical Genitourinary Cancer|December 3, 2014
Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamideAndrew J Cowan, Yoshio Inoue, Evan Y Yu
Clinical Genitourinary Cancer|August 28, 2014
Long-term survival in bone-predominant metastatic urothelial carcinomaJorge D Ramos, Heather H Cheng, Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Honing in on PARPi Response in Prostate Cancer: from HR Pathway to Gene-by-Gene GranularityAlexandra O Sokolova, Evan Y Yu, Heather H Cheng
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2021
BiTE-ing into Prostate Cancer with Bispecific T-cell EngagersNikhil V Kamat, Evan Y Yu, John K Lee
Pageof 24